Document is current
Any future updates will be listed below
-
Authors
Post, Annelies S. https://orcid.org/0000-0002-0471-8250
Guiraud, I. https://orcid.org/0000-0002-6726-3898
Peeters, M.
Lompo, P. https://orcid.org/0000-0002-7547-2892
Ombelet, S. https://orcid.org/0000-0002-4943-0736
Karama, I.
Yougbaré, S. https://orcid.org/0000-0003-4721-2804
Garba, Z.
Rouamba, E.
Tinto, H. https://orcid.org/0000-0003-4653-7041
Jacobs, Jan https://orcid.org/0000-0002-8657-6777
- License Information
-
More Information
Article History
Received: 31 July 2021
Accepted: 3 August 2022
First Online: 5 September 2022
Declarations
:
: The study was approved by the national ethics committee of Burkina Faso (Comité d’Ethique pour la Recherche en Santé (Reference No 2015-7-96 July 1st, 2015), the institutional review board of ITM, Antwerp (Reference 1008/15 from December 15th, 2015) and the ethics committee of the University Hospital of Antwerp (Reference 15/51/563, January 4th, 2016). Written informed consent was obtained before participation in the study. A screening log with reasons for refusal was completed at each health center included in the study. If ASB was diagnosed, laboratory staff of the study site communicated the recovery of clinically significant isolates and their AST results to the study investigator, who informed the ANC nurse or the clinician responsible of the ANC. Participants were treated according to national treatment guidelines.
: All authors have read the manuscript and consent to publish.
: None of the authors have competing interests to declare.
